BrightView vs Healthcare Services
BV and HCSG side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BV and HCSG compare
Healthcare Services is the larger company, worth 1.9 times as much as BrightView ($1.7B against $914M).
Healthcare Services grew revenue faster over the last twelve months (4.0% versus 1.5% for BrightView).
Healthcare Services keeps more of each dollar of sales as profit, with a net margin of 5.6% compared with 0.04% at BrightView.
Healthcare Services scores higher on the StockData Score (18 against 5 for BrightView), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BV | HCSG |
|---|---|---|
| Size and price | ||
| Market cap | $914M | $1.7B |
| Share price | $9.87 | $25.21 |
| Change, 1 year | −16.9% | 43.3% |
| Change, 5 years | −36.0% | 35.8% |
| Beta (5Y) | 1.05 | 0.77 |
| Employees | 18K | 36K |
| StockData Score | ||
| Total score | 5 | 18 (better) |
| Valuation score | 1 | 5 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 16.9× |
| P/S | 0.3× (better) | 0.9× |
| P/B | 0.7× (better) | 3.2× |
| EV/EBITDA | 24.1× | 10.7× (better) |
| P/FCF | – | 15.9× |
| PEG | – | 0.82 |
| FCF yield | −4.4% | 6.3% (better) |
| Fair value | $3.59 | $30.43 |
| Margin of safety | −175% | 17.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.5% | 4.0% (better) |
| Revenue growth, 5Y average | 1.2% (better) | 0.86% |
| Net income growth (TTM) | −98.2% | 164% (better) |
| EPS growth (TTM) | −385% | 176% (better) |
| EPS growth, 5Y average | – | −9.3% |
| Profitability | ||
| Gross margin | 20.4% (better) | 16.1% |
| Operating margin | 2.8% | – |
| Net margin | 0.04% | 5.6% (better) |
| FCF margin | −1.5% | 5.7% (better) |
| Return on equity | 0.08% | 20.4% (better) |
| Return on invested capital | 1.8% | – |
| Financial health | ||
| Debt / equity | 0.72 (better) | 0.00 |
| Net debt / EBITDA | 11.84 | – |
| Interest coverage | 1.4× | – |
| Current ratio | 1.29 | 2.82 (better) |
| Altman Z-score | 1.23 | 6.53 (better) |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Buyback yield | 6.1% (better) | 4.5% |
| Shareholder yield | 6.1% (better) | 4.5% |
| Ownership | ||
| Held by institutions | 103% | 108% |
| Held by insiders | 26.2% | 1.3% |
| Insider net buying, 12 months | $316K (better) | −$3.8M |
| Short interest, % of float | 6.1% | 3.7% |
Go deeper
- BV stock overview
- BV income statement
- BV valuation and score
- HCSG stock overview
- HCSG income statement
- HCSG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.